- Home
- WFF vs ENLV Comparison
WFF vs ENLV Comparison
Compare WFF & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WFF
- ENLV
- Stock Information
- Founded
- WFF 1984
- ENLV 2005
- Country
- WFF Malaysia
- ENLV Israel
- Employees
- WFF N/A
- ENLV N/A
- Industry
- WFF Miscellaneous manufacturing industries
- ENLV Biotechnology: Pharmaceutical Preparations
- Sector
- WFF Consumer Discretionary
- ENLV Health Care
- Exchange
- WFF Nasdaq
- ENLV Nasdaq
- Market Cap
- WFF 22.4M
- ENLV 25.3M
- IPO Year
- WFF 2025
- ENLV 1995
- Fundamental
- Price
- WFF $0.90
- ENLV $1.06
- Analyst Decision
- WFF
- ENLV Strong Buy
- Analyst Count
- WFF 0
- ENLV 2
- Target Price
- WFF N/A
- ENLV $10.00
- AVG Volume (30 Days)
- WFF 112.3K
- ENLV 1.2M
- Earning Date
- WFF 01-01-0001
- ENLV 08-29-2025
- Dividend Yield
- WFF N/A
- ENLV N/A
- EPS Growth
- WFF N/A
- ENLV N/A
- EPS
- WFF 0.00
- ENLV N/A
- Revenue
- WFF $4,572,290.00
- ENLV N/A
- Revenue This Year
- WFF N/A
- ENLV N/A
- Revenue Next Year
- WFF N/A
- ENLV N/A
- P/E Ratio
- WFF $185.11
- ENLV N/A
- Revenue Growth
- WFF N/A
- ENLV N/A
- 52 Week Low
- WFF $0.81
- ENLV $0.81
- 52 Week High
- WFF $29.26
- ENLV $2.10
- Technical
- Relative Strength Index (RSI)
- WFF N/A
- ENLV 40.76
- Support Level
- WFF N/A
- ENLV $1.01
- Resistance Level
- WFF N/A
- ENLV $1.13
- Average True Range (ATR)
- WFF 0.00
- ENLV 0.11
- MACD
- WFF 0.00
- ENLV -0.02
- Stochastic Oscillator
- WFF 0.00
- ENLV 10.39
About WFF WF Holding Limited Ordinary Shares
WF Holding Ltd is a manufacturer of FRP products based in Malaysia. It has been providing high-quality and durable FRP products to various industries, including, among others, chemical processing, water and wastewater treatment, and power generation. Its products range from tanks, pipes, ducts, gratings and other custom-made FRP products. The company uses advanced production technology and equipment and has obtained various certifications. Its manufacturing capabilities allow the company to design and fabricate products that meet the specific needs of its clients, ensuring high-quality and reliable performance.
About ENLV Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.